Guidant (GDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jbershad who wrote (117)	5/14/1998 3:56:00 PM
From: MU Lation	of 235

Its been so quiet around here! Thursday May 14, 2:42 pm Eastern Time RESEARCH ALERT-Guidant EPS estimate raised CHICAGO, May 14 (Reuters) - J.P. Morgan Securities said Thursday it raised its 1999 earnings per share estimate on medical device supplier Guidant Corp. (GDT - news) to $2.55 from $2.50. -- said in a report the higher estimate was based on ''increasing confidence in the company's ability to grow its pacing business over the next two years well in excess of market rates, and management's ability to control costs and boost margins in 1999 in excess of prior expectations.'' -- Guidant makes pacemakers and cardioverter defibrillators, which detect and treat abnormal heartbeats, as well as stents and other products to open blocked arteries. -- J.P. Morgan said it expected 14 percent sales growth in Guidant's pacing business in 1999 and at least 14 percent in 1998. -- said it may increase its 1999 earnings estimate again, depending on stent pricing, the impact of new stent products on the company's market share, and other factors. -- estimated 1998 earnings of $2.22 per share, reiterated its buy rating on the stock and repeated its 12-month stock price target of $84. -- The stock was 2-13/16 higher at 66-7/16 Thursday afternoon. MU

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next